Evelyn Partners Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33M Sell
135,066
-2,708
-2% -$631K 0.9% 28
2025
Q4
$28.5M Sell
137,774
-6,398
-4% -$1.27M 0.79% 32
2025
Q3
$26.7M Sell
144,172
-8,955
-6% -$1.53M 0.76% 33
2025
Q2
$23.4M Sell
153,127
-3,688
-2% -$567K 0.72% 35
2025
Q1
$26M Sell
156,815
-3,087
-2% -$483K 0.87% 29
2024
Q4
$23.1M Buy
+159,902
New +$24.8M 0.75% 35

Other funds holding JNJ

Evelyn Partners Investment Management's JNJ Position: Q1 2026 in Review

Evelyn Partners Investment Management reduced its Johnson & Johnson (JNJ) stake by 2% in Q1 2026, selling an estimated $631K and leaving 135,066 shares worth $33M. The position accounts for 0.9% of the portfolio, ranked #28.

Evelyn Partners Investment Management first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,621 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Evelyn Partners Investment Management held 135,066 shares of Johnson & Johnson worth $33M as of Q1 2026.
  • Evelyn Partners Investment Management sold 2,708 Johnson & Johnson shares in Q1 2026, an estimated $631K.
  • Johnson & Johnson made up 0.9% of Evelyn Partners Investment Management's portfolio in Q1 2026, its #28 holding.
  • Evelyn Partners Investment Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,621 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Evelyn Partners Investment Management's 13F filing for Q1 2026, filed 15 May 2026.